Caixin
Aug 31, 2022 08:00 AM

Jiangsu Wuzhong Pharmaceutical Development Co.,Ltd. Posted 20.5 Million Yuan Net Loss in First Half of 2022

Jiangsu Wuzhong Pharmaceutical Development Co.,Ltd. (江苏吴中医药发展股份有限公司) (600200.SH) reported a net loss of 20.5 million yuan in the first half of 2022, reversing a net profit of 68.5 million yuan for the same period in the previous year.

Meanwhile, the company posted 786.1 million yuan in revenue, down 24% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 48%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Business Uncovered Podcast: Brazil’s ‘Very Chinese Moment’
00:00
00:00/00:00